Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy.

OBJECTIVE

SYNGAP1-related disorders are common neurodevelopmental conditions characterized by autism spectrum disorder, developmental delay, intellectual disability, and a range of generalized seizure types. Disease-causing variants in SYNGAP1 typically occur de novo. This study aims to characterize inherited cases of SYNGAP1-related disorders.

METHODS

Here we report three families including eight total individuals with inherited, protein-truncating variants in SYNGAP1, recruited through a natural history study. In two of the families, the proband inherited their pathogenic variant from a heterozygous parent. In the remaining family, the variant was inherited from a mosaic parent. This study additionally reports two families with inherited missense variants classified as variants of uncertain significance, which are not clearly diagnostic at this time.

RESULTS

Phenotypes in affected children and parents included both typical and attenuated SYNGAP1 presentations, including a single individual with a mosaic SYNGAP1 variant who was clinically unaffected. Among the individuals with protein-truncating variants, generalized epilepsy was observed in six individuals, autism spectrum disorder in two individuals, and developmental delay or intellectual disability in all individuals with germline variants.

SIGNIFICANCE: We demonstrate that SYNGAP1-related disorder can occur in families and that clinical presentations of familial cases are not limited to milder phenotypes. We estimate that 3% of cases of SYNGAP1-related disorder are inherited. Recognition of familial SYNGAP1-related disorders delineates edge cases of a relatively common neurodevelopmental disorder and has implications for variant interpretation and clinical practice.